Trial · NCT00422058
Participant flow42
How many started, completed or left each group, period by period.
1 to 20 of 42
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double-Blind, Week 0-20 | STARTED | Lira Placebo/Lira 2.4 mg/Lira 3.0 mg | 98 | |
| Double-Blind, Week 0-20 | STARTED | Lira 1.2 mg/Lira 3.0 mg | 95 | |
| Double-Blind, Week 0-20 | STARTED | Lira 1.8 mg/Lira 3.0 mg | 90 | |
| Double-Blind, Week 0-20 | STARTED | Lira 2.4 mg/Lira 3.0 mg | 93 | |
| Double-Blind, Week 0-20 | STARTED | Liraglutide 3.0 mg | 93 | |
| Double-Blind, Week 0-20 | STARTED | Orlistat | 95 | |
| Double-Blind, Week 0-20 | COMPLETED | Lira Placebo/Lira 2.4 mg/Lira 3.0 mg | 79 | |
| Double-Blind, Week 0-20 | COMPLETED | Lira 1.2 mg/Lira 3.0 mg | 85 | |
| Double-Blind, Week 0-20 | COMPLETED | Lira 1.8 mg/Lira 3.0 mg | 74 | |
| Double-Blind, Week 0-20 | COMPLETED | Lira 2.4 mg/Lira 3.0 mg | 73 | |
| Double-Blind, Week 0-20 | COMPLETED | Liraglutide 3.0 mg | 82 | |
| Double-Blind, Week 0-20 | COMPLETED | Orlistat | 79 | |
| Double-Blind, Week 0-20 | NOT COMPLETED | Lira Placebo/Lira 2.4 mg/Lira 3.0 mg | 19 | |
| Double-Blind, Week 0-20 | NOT COMPLETED | Lira 1.2 mg/Lira 3.0 mg | 10 | |
| Double-Blind, Week 0-20 | NOT COMPLETED | Lira 1.8 mg/Lira 3.0 mg | 16 | |
| Double-Blind, Week 0-20 | NOT COMPLETED | Lira 2.4 mg/Lira 3.0 mg | 20 | |
| Double-Blind, Week 0-20 | NOT COMPLETED | Liraglutide 3.0 mg | 11 | |
| Double-Blind, Week 0-20 | NOT COMPLETED | Orlistat | 16 | |
| Open-Label Extension, Week 20-104 | STARTED | Lira Placebo/Lira 2.4 mg/Lira 3.0 mg | 79 | |
| Open-Label Extension, Week 20-104 | STARTED | Lira 1.2 mg/Lira 3.0 mg | 85 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00422058/flow